These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 39076869)

  • 1. Omega-3 Polyunsaturated Fatty Acids Supplements and Cardiovascular Disease Outcome: A Systematic Review and Meta-Analysis on Randomized Controlled Trials.
    Qi X; Zhu H; Ya R; Huang H
    Rev Cardiovasc Med; 2023 Jan; 24(1):24. PubMed ID: 39076869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials.
    Casula M; Olmastroni E; Gazzotti M; Galimberti F; Zambon A; Catapano AL
    Pharmacol Res; 2020 Oct; 160():105060. PubMed ID: 32634581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Omega-3 Fatty Acids in the Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis.
    Yan J; Liu M; Yang D; Zhang Y; An F
    Cardiovasc Drugs Ther; 2024 Aug; 38(4):799-817. PubMed ID: 36103100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review.
    Balk EM; Adams GP; Langberg V; Halladay C; Chung M; Lin L; Robertson S; Yip A; Steele D; Smith BT; Lau J; Lichtenstein AH; Trikalinos TA
    Evid Rep Technol Assess (Full Rep); 2016 Aug; (223):1-1252. PubMed ID: 30307737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease.
    Abdelhamid AS; Martin N; Bridges C; Brainard JS; Wang X; Brown TJ; Hanson S; Jimoh OF; Ajabnoor SM; Deane KH; Song F; Hooper L
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012345. PubMed ID: 30484282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-6 fatty acids and the risk of cardiovascular disease: insights from a systematic review and meta-analysis of randomized controlled trials and a Mendelian randomization study.
    Mazidi M; Shekoohi N; Katsiki N; Banach M
    Arch Med Sci; 2022; 18(2):466-479. PubMed ID: 35316920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omega-6 fats for the primary and secondary prevention of cardiovascular disease.
    Hooper L; Al-Khudairy L; Abdelhamid AS; Rees K; Brainard JS; Brown TJ; Ajabnoor SM; O'Brien AT; Winstanley LE; Donaldson DH; Song F; Deane KH
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011094. PubMed ID: 30488422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Long-Term Marine ɷ-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.
    Gencer B; Djousse L; Al-Ramady OT; Cook NR; Manson JE; Albert CM
    Circulation; 2021 Dec; 144(25):1981-1990. PubMed ID: 34612056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 Fatty Acid Supplementation and Coronary Heart Disease Risks: A Meta-Analysis of Randomized Controlled Clinical Trials.
    Shen S; Gong C; Jin K; Zhou L; Xiao Y; Ma L
    Front Nutr; 2022; 9():809311. PubMed ID: 35187035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of omega-3 polyunsaturated fatty acids supplementation for patients with cardiovascular disease risks: a dose-response meta-analysis.
    Xie L; Zhen P; Wei Q; Yu F; Song S; Tong J
    Am J Transl Res; 2021; 13(8):8526-8539. PubMed ID: 34539977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of glucagon-like peptide-1 receptor agonists on major cardiovascular events in patients with Type 2 diabetes mellitus with or without established cardiovascular disease: a meta-analysis of randomized controlled trials.
    Marsico F; Paolillo S; Gargiulo P; Bruzzese D; Dell'Aversana S; Esposito I; Renga F; Esposito L; Marciano C; Dellegrottaglie S; Iesu I; Perrone Filardi P
    Eur Heart J; 2020 Sep; 41(35):3346-3358. PubMed ID: 32077924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G
    Eur J Prev Cardiol; 2024 Nov; 31(15):1863-1875. PubMed ID: 38869144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of omega-3 polyunsaturated fatty acid supplementation on the incidence of cardiovascular events and complications in peripheral arterial disease: a systematic review and meta-analysis.
    Enns JE; Yeganeh A; Zarychanski R; Abou-Setta AM; Friesen C; Zahradka P; Taylor CG
    BMC Cardiovasc Disord; 2014 May; 14():70. PubMed ID: 24885361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking cessation for secondary prevention of cardiovascular disease.
    Wu AD; Lindson N; Hartmann-Boyce J; Wahedi A; Hajizadeh A; Theodoulou A; Thomas ET; Lee C; Aveyard P
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD014936. PubMed ID: 35938889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of omega-3, omega-6, and total dietary polyunsaturated fatty acid supplementation in patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis.
    Luo S; Hou H; Wang Y; Li Y; Zhang L; Zhang H; Jin Q; Wu G; Wang X
    Food Funct; 2024 Feb; 15(3):1208-1222. PubMed ID: 38224465
    [No Abstract]   [Full Text] [Related]  

  • 17. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis.
    Rizos EC; Ntzani EE; Bika E; Kostapanos MS; Elisaf MS
    JAMA; 2012 Sep; 308(10):1024-33. PubMed ID: 22968891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 fatty acids for the treatment of dementia.
    Burckhardt M; Herke M; Wustmann T; Watzke S; Langer G; Fink A
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD009002. PubMed ID: 27063583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Omega-3 fatty acid on major cardiovascular events and mortality in patients with coronary heart disease: a meta-analysis of randomized controlled trials.
    Wen YT; Dai JH; Gao Q
    Nutr Metab Cardiovasc Dis; 2014 May; 24(5):470-5. PubMed ID: 24472636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Outcomes in Patients with Diabetes: A Meta-analysis of Randomized Controlled Trials.
    Huang L; Zhang F; Xu P; Zhou Y; Liu Y; Zhang H; Tan X; Ge X; Xu Y; Guo M; Long Y
    Adv Nutr; 2023 Jul; 14(4):629-636. PubMed ID: 37121469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.